A carregar...

Hsp90 inhibitor 17-AAG inhibits progression of LuCaP35 xenograft prostate tumors to castration resistance

BACKGROUND: Advanced prostate cancer is currently treated with androgen deprivation therapy (ADT). ADT initially results in tumor regression, however, all patients eventually relapse with castration-resistant prostate cancer. New approaches to delay the progression of prostate cancer to castration r...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: O’Malley, Katherine J., Langmann, Gabrielle, Ai, Junkui, Ramos-Garcia, Raquel, Vessella, Robert L., Wang, Zhou
Formato: Artigo
Idioma:Inglês
Publicado em: 2011
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3319476/
https://ncbi.nlm.nih.gov/pubmed/22161776
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/pros.22458
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!